Articles Referencing PBA

Zacks.com

PVR Partners Upgraded to Neutral - Analyst Blog

On May 16, 2013, we upgraded our recommendation on PVR Partners L.P. ( PVR ) to Neutral from Underperform. The partnership currently has a Zacks Rank #3 (Hold). Why the Upgrade? There... Read >>

Zacks.com

SM Energy Prices Notes Worth $500M - Analyst Blog

Independent oil and gas company, SM Energy Company ( SM ) has recently announced the pricing of senior unsecured notes aggregating $500 million. These notes with a coupon rate of 5% are to... Read >>

Zacks.com

Wider-than-Expected Loss at Avanir - Analyst Blog

Avanir Pharmaceuticals, Inc. ( AVNR ) reported second quarter fiscal 2013 net loss per share of 12 cents, wider than the Zacks Consensus Estimate of a loss of 9 cents, but narrower... Read >>

Zacks.com

Positive CHMP Opinion for Avanir - Analyst Blog

Avanir Pharmaceuticals, Inc. ( AVNR ) recently received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for Nuedexta. Nuedexta is under review in the EU... Read >>

NASDAQ.com News

Pembina Pipeline Corp. (PBA) Ex-Dividend Date Scheduled for April 23, 2013

Pembina Pipeline Corp. ( PBA ) will begin trading ex-dividend on April 23, 2013. A cash dividend payment of $0.1316 per share is scheduled to be paid on May 15, 2013. Shareholders who purchased... Read >>

Zacks.com

Wider-Than-Expected Loss at Avanir - Analyst Blog

Avanir Pharmaceuticals, Inc. ( AVNR ) reported first quarter fiscal 2013 net loss per share of 9 cents, wider than the Zacks Consensus Estimate of a loss of 8 cents, but narrower than the... Read >>